These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16041272

  • 1. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.
    Transplantation; 2005 Jul 27; 80(2):255-63. PubMed ID: 16041272
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.
    Transplantation; 2005 Aug 27; 80(4):546-54. PubMed ID: 16220623
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, Tezuka K, Makuuchi M, Suzuki S, Li XK.
    Transpl Immunol; 2003 Aug 27; 12(1):41-8. PubMed ID: 14551031
    [Abstract] [Full Text] [Related]

  • 4. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.
    Ozkaynak E, Gao W, Shemmeri N, Wang C, Gutierrez-Ramos JC, Amaral J, Qin S, Rottman JB, Coyle AJ, Hancock WW.
    Nat Immunol; 2001 Jul 27; 2(7):591-6. PubMed ID: 11429542
    [Abstract] [Full Text] [Related]

  • 5. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, Anderson CC, Shapiro AM.
    Diabetes; 2006 Jan 27; 55(1):27-33. PubMed ID: 16380473
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Brook MO, Jones ND, Wood KJ.
    Transplantation; 2005 Jul 27; 80(2):253-4. PubMed ID: 16041271
    [No Abstract] [Full Text] [Related]

  • 7. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
    Guillonneau C, Hill M, Hubert FX, Chiffoleau E, Hervé C, Li XL, Heslan M, Usal C, Tesson L, Ménoret S, Saoudi A, Le Mauff B, Josien R, Cuturi MC, Anegon I.
    J Clin Invest; 2007 Apr 27; 117(4):1096-106. PubMed ID: 17404623
    [Abstract] [Full Text] [Related]

  • 8. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients.
    Guillonneau C, Séveno C, Dugast AS, Li XL, Renaudin K, Haspot F, Usal C, Veziers J, Anegon I, Vanhove B.
    J Immunol; 2007 Dec 15; 179(12):8164-71. PubMed ID: 18056359
    [Abstract] [Full Text] [Related]

  • 9. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
    Kosuge H, Suzuki J, Gotoh R, Koga N, Ito H, Isobe M, Inobe M, Uede T.
    Transplantation; 2003 Apr 27; 75(8):1374-9. PubMed ID: 12717233
    [Abstract] [Full Text] [Related]

  • 10. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C, Guillonneau C, Mathieu P, Gerdes CA, Ménoret S, Braudeau C, Tesson L, Renaudin K, Castro MG, Löwenstein PR, Anegon I.
    J Immunol; 2002 Feb 15; 168(4):1600-9. PubMed ID: 11823487
    [Abstract] [Full Text] [Related]

  • 11. Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation.
    Guo L, Li XK, Enosawa S, Funeshima N, Suzuki S, Kimura H, Sugawara Y, Tezuka K, Makuuchi M.
    Liver Transpl; 2004 Jun 15; 10(6):743-7. PubMed ID: 15162468
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. AdCTLA-4Ig combined with donor splenocytes, bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model.
    Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, Tezuka K, Makuuchi M, Suzuki S, Li XK.
    Transpl Int; 2004 Jan 15; 17(1):15-21. PubMed ID: 12942167
    [Abstract] [Full Text] [Related]

  • 14. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
    Wang Z, Morelli AE, Hackstein H, Kaneko K, Thomson AW.
    Transplantation; 2003 Aug 15; 76(3):562-71. PubMed ID: 12923445
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.
    Wu G, Pfeiffer S, Schröder C, Zhang T, Nguyen BN, Lea W, Kelishadi S, Atkinson JB, Schuurman HJ, White DJ, Azimzadeh AM, Pierson RN.
    Xenotransplantation; 2005 May 15; 12(3):197-208. PubMed ID: 15807770
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K, Kotani M, Omoto K, Kobayashi S, Tanabe K, Shimmura H, Suzuki K, Hayashi T, Toma H, Abe R.
    Transplantation; 2003 Sep 15; 76(5):854-8. PubMed ID: 14501867
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of costimulatory pathway modulation on corneal allograft survival.
    Watson MP, George AJ, Larkin DF.
    Invest Ophthalmol Vis Sci; 2006 Aug 15; 47(8):3417-22. PubMed ID: 16877411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.